Publications on the therapeutic potential of antioxidant therapeutics and in particular on MetrioPharm’s lead compound MP1032
Immune-Modulating Drug MP1032 with SARS-CoV-2
SARS-CoV-2 and mitochondrial health:
An overview of the state of scientific research on oxidative stress, inflamm-aging, and therapy of chronic inflammatory diseases
Here you will find links to websites operated by third parties. If you use these links, you will leave our website. These links are provided for your convenience and do not constitute an endorsement by MetrioPharm AG of the content of such linked websites. MetrioPharm AG has no control over the content of any linked website and is not responsible for those websites or their content or availability. MetrioPharm AG therefore makes no warranties or representations, express or implied, regarding such linked websites, or the information contained therein.